Samah Salem S. Basudan

A dedicated and results-driven clinical pharmacist with over a decade of experience in internal medicine especially nephrology. Possessing a strong foundation in clinical pharmacotherapy, therapeutic drug monitoring, and patient safety, with specialized expertise in the management of acute kidney injury (AKI) and chronic kidney disease (CKD). Demonstrates advanced proficiency in renal dose adjustments, monitoring nephrotoxic agents, managing complex electrolyte imbalances, and optimizing therapy for renal anemia, blood pressure, and glycemic control in kidney-impaired patients.

Highly experienced in leading pharmacy services across high-acuity hospital settings, supervising clinical teams, and developing national-level therapeutic protocols. Consistently handles a high patient caseload (25–30 patients/day) with over 100 monthly documented interventions, reflecting a sustained commitment to efficiency, accuracy, and evidence-based care. Recognized for collaborative leadership, clinical decision-making, and contributions to hospital committees and formulary management.

Deeply passionate about nephrology and advancing clinical pharmacy practice in renal care, with a long-term goal of becoming a leader in the field. Committed to continuous learning, professional development, and mentoring the next generation of pharmacists to enhance patient outcomes and elevate the standard of care within multidisciplinary healthcare systems.

I am eager to bring this nephrology expertise into your advanced training program and continue refining the skills necessary to become a national leader in renal pharmaceutical care.

• Certificate of Attendance Train the Trainer Clinical Teaching and Assessment, KAMC, Jeddah, Saudi Arabia, 2024
• Certificate of Attendance Train of Trainer (TOT), KFH, Jeddah, Saudi Arabia, 2023

Awards

• Certificate of Thanks and Appreciation for Clinical Pharmacy PGY1 Accreditation in Jeddah Region, Directorate of Health Affairs, Jeddah, Saudi Arabia, 2024
• Certificate of Thanks and Appreciation for Reviewing and Writing Protocols, General Pharmaceutical Care Administration, Riyadh, Saudi Arabia, 2022
• Certificate of Thanks and Appreciation for Participation as Speaker in Workshop, Pharmaceutical Care Administration, Riyadh, Saudi Arabia, 2022
• Certificate of Thanks and Appreciation from King Abdulaziz University for Training Internship Students, 2021
• 
  
• Certificate of Thanks and Appreciation for Participation in Internal Medicine Clinical Pharmacy Services, Pharmaceutical Care Administration, Riyadh, Saudi Arabia, 2021
• Certificate of Thanks and Appreciation for Leading IM Clinical Service Program, Pharmaceutical Care Administration, Riyadh, Saudi Arabia, 2021
• Certificate of Participation in 1st National Hospital Pharmacy Competition (NHPC2020), 2020
• Certificate of Thanks and Appreciation for Writing and Presenting a Protocol of Antibiotics Therapeutic Drug Monitoring for Pediatrics and Neonate, Pharmaceutical Care Administration, Riyadh, Saudi Arabia, 2019
• Certificate of Thanks and Appreciation from Umm Al-qura University for Training Internship Students, 2018
• 
  

Research project

2025

Participate in research project “Molecular Pharmacology of Glucagon-Like Peptide 1-Based Therapies in the Management of Type Two Diabetes Mellitus and Obesity” published in 6 April 2025 https://www.dovepress.com/molecular-pharmacology-of-glucagon-like-peptide-1-based-therapies-in-t-peer-reviewed-fulltext-article-IPRP

2023

Participate in research project” The Bayesian-Based Area under the Curve of

Vancomycin by Using a Single Trough Level: An Evaluation of Accuracy and

Discordance at Tertiary Care Hospital in KSA” published in 27 Jan 2023

https://www.mdpi.com/2227-9032/11/3/362

2022

Participate in research project”Augmented renal clearance and

hypoalbuminemia induced low vancomycin trough concentration in febrile

neutropenic patients with hematological malignancies” published in Cureus 25

Sep. 2022 https://www.cureus.com/articles/115017#!/

Participate in research project” Carbapenem-resistant enterobacteriaceae: an

update and treatment option” articles reviewed under process of publication.

2021

Participate in research project “causes of vancomycin dosing error; problem

detection and practical solutions; a retrospective, single-center, cross-

sectional study” published in SPJ 6 may 2021

“https://www.sciencedirect.com/science/article/pii/S1319016421000803”

Research project titled “Effectiveness of Favipiravir in covid-19” retrospective

multicenter study, KFH, Jeddah, Saudi Arabia.

2017

Participate in research project “irrational drug use for antibiotic combinations

and primary diagnosis in medical wards for pediatrics, pilot study” MCH,

Makkah, Saudi Arabia.

2016

PGY1 graduation Research project titled " Effectiveness of educational

intervention on patient' adherence to clozapine monitoring protocols", RCT.

KSUMC, Riyadh, Saudi Arabia.

2012

Pharm D Graduation research project titled "effect of zinc supplementation on

type II diabetes: A single blinded, randomized trial". UQU, Makkah, Saudi

Arabia.

• Protocols

2025

Update Protocol of Glycemic Control in Noncritical Hospitalized Patients, General

Administration of Pharmaceutical Care, Riyadh, Saudi Arabia.

2021

VTE protocol, General Administration of Pharmaceutical Care, Riyadh, Saudi

Arabia.

Protocol of Glycemic Control in Noncritical Hospitalized Patients, General

Administration of Pharmaceutical Care, Riyadh, Saudi Arabia.

Protocol of Stress Ulcer Prophylaxis (SUP), General Administration of

Pharmaceutical Care, Riyadh, Saudi Arabia.

Protocol of Warfarin monitoring, General Administration of Pharmaceutical

Care, Riyadh, Saudi Arabia.

- 2020

Protocol of antibiotics therapeutic drug monitoring for pediatrics and neonate,

General Administration of Pharmaceutical Care, Riyadh, Saudi Arabia.

• Posters

“Causes of vancomycin dosing error; problem detection and practical

solutions; a retrospective, single-center, cross-sectional study” SIPHA, Riyadh,

Saudi Arabia.

“Irrational drug use for antibiotic combinations and primary diagnosis in

medical wards for pediatrics, pilot study” DUPHAT, Dubai, UAE.

2012

“Effect of zinc supplementation on type II diabetes: A single blinded,

randomized trial”, UQU, Makkah, Saudi Arabia.

• Speaker

2023

Participate as speaker in HTN word day done by General Administration of

Pharmaceutical Care, Riyadh, Saudi Arabia.

Participate as speaker in Critical care nutrition and beyond activity held at

KAMC, Jeddah, Saudi Arabia.

2022

Participate as speaker in diabetes mellitus patient education workshop done

by General Administration of Pharmaceutical Care, Riyadh, Saudi Arabia.

Participate as speaker in Anticoagulant stewardship workshop done by

pharmaceutical care administration, Riyadh, Saudi Arabia.

Participate as speaker in a nursing Qualifying course workshop done by

pharmaceutical care administration, Riyadh, Saudi Arabia.

2020

Participated as a speaker in antibiotics therapeutic drug monitoring for

pediatrics and neonatal workshops, done by General Administration of

Pharmaceutical Care, Riyadh, Saudi Arabia.

• Dr. Mohammed Alshannawi, General Director, General Administration of Pharmaceutical Care, MOH, Riyadh, 2024
• Dr. Bandar Alamri, Consultant Infectious Disease, KAMC, Jeddah, 2023
• Dr. Alaa Mutlaq, Clinical Pharmacist Consultant IM, Manager of Clinical Pharmacy in MOH, Riyadh, 2022
• Dr. Wail Bagahmoom, Head of Internal Medicine Department, ID Consultant, KFH, Jeddah, 2021
• Dr. Sami Billa, Internal Medicine Consultant, KFH, Jeddah, 2021
• Dr. Shereen Al Dasogi, ICU Clinical Pharmacist, KSUMC, Riyadh, 2016
• Dr. Esraa Al Tawil, TPN Clinical Pharmacist, KSUMC, Riyadh, 2016
• Dr. Fakhr Al Ayoubi, Senior Cardiology Clinical Pharmacist, KSUMC, Riyadh, 2016